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SUMMARY
The mammalian imprinted Dlk1-Gtl2 locus produces multiple non-coding RNAs (ncRNAs) from 
the maternally inherited allele, including the largest miRNA cluster in the mammalian genome. 
This locus has characterized functions in some types of stem cell, but its role in hematopoietic 
stem cells (HSCs) is unknown. Here, we show that the Dlk1-Gtl2 locus plays a critical role in 
preserving long-term repopulating HSCs (LT-HSCs). Through transcriptome profiling in 17 
hematopoietic cell types, we found that ncRNAs expressed from the Dlk1-Gtl2 locus are 
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predominantly enriched in fetal liver HSCs and the adult LT-HSC population and sustain long-
term HSC functionality. Mechanistically, the miRNA mega-cluster within the Dlk1-Gtl2 locus 
suppresses the entire PI3K-mTOR pathway. This regulation in turn inhibits mitochondrial 
biogenesis and metabolic activity and protects LT-HSCs from excessive reactive oxygen species 
(ROS) production. Our data therefore show that the imprinted Dlk1-Gtl2 locus preserves LT-HSC 
function by restricting mitochondrial metabolism.
In Brief
Qian and colleagues show that ncRNAs expressed from the imprinted locus Dlk1-Gtl2 maintain 
fetal liver and adult LT-HSCs through multiplexed inhibition of PI3K-mTOR signaling that in turn 
keeps mitochondrial biogenesis and metabolic activity in check.
INTR ODUCTION
Homeostasis in hematopoiesis requires a balance between stem cell maintenance and action 
to prevent bone marrow (BM) from exhaustion or overgrowth (Li and Clevers, 2010; Wilson 
et al., 2008). Cell-cycle status is essential for regulation of this balance, by which long-term 
(LT)-HSCs are preserved in a quiescent state for maintenance whereas short-term (ST)-
HSCs and multipotent progenitor (MPP) cells are fast cycling for increasing cell mass and 
further differentiation (Yang et al., 2005). Previous studies reported that surface marker 
CD49b (Integrin α2) could further separate conventional LT-HSCs 
(CD34−Flk2−Lineage−Sca-1+c-Kit+ [LSK]) into CD49blo LT-HSCs that maintain permanent 
reconstituting ability and CD49bhi intermediate-term (IT)-HSCs that support only 6–8 
months of multipotent hematopoiesis (Benveniste et al., 2010). Recent studies reported that 
metabolic properties are required for maintenance of different states of HSCs (Suda et al., 
2011; Takubo et al., 2013), and a low mitochondrial potential correlates with HSC 
functionality (Simsek et al., 2010). How cell-cycle status and metabolic states are precisely 
controlled in HSCs remains largely unknown.
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Epigenetic regulation, including ncRNAs, DNA methylation, histone modification, and 
chromatin remodeling, plays essential roles in orchestrating the balance between HSC 
maintenance and action (Cullen et al., 2014). Genomic imprinting, a unique epigenetic 
regulation resulting in a parent-of-origin-specific gene expression, is essential for normal 
mammalian development and growth (Bartolomei, 2009; Ferguson-Smith, 2011). We 
initiated our study on imprinting genes after seeing a differential expression of imprinted 
genes in HSCs (Haug et al., 2008). Systematic gene profiling conducted by several groups 
revealed predominant expression of imprinted genes in HSCs as well as other somatic stem 
cells (Berg et al., 2011; Ferrón et al., 2011; Zacharek et al., 2011). We further functionally 
proved that the imprinting at the H19-Igf2 locus is essential for maintaining HSC quiescence 
via suppression of Igf1r expression by H19-derived miR-675 (Venkatraman et al., 2013). In 
addition to miRNAs, long-length non-coding RNAs (lncRNAs) (>200 nt in length) have 
drawn attention for their potential regulatory roles in biological processes including stem 
cell property (Luo et al., 2015). These efforts have sparked interest in ncRNAs; however, 
whether and how ncRNAs preserve LT-HSCs remains poorly understood.
In this study, we performed transcriptome profiling in 17 sub-populations of hematopoietic 
stem, progenitor, and mature lineage cells, and we identified exclusively expressed 
“fingerprint” lncRNAs unique to each cell type. We found that lncRNAs in the Dlk1-Gtl2 
locus are specifically enriched in the CD49blo LT-HSCs. The imprinted Dlk1-Gtl2 locus 
contains three protein-coding genes (Dlk1, Rtl1, and Dio3) on the paternally inherited allele 
and multiple lncRNAs and small ncRNAs on the maternally inherited allele, including Gtl2, 
Rian (containing 22 box C/D snoRNAs), and the largest miRNA mega-cluster in mammals 
(anti-Rtl1, which contains the miR-127/miR-136 cluster with 7 miRNAs, and Mirg, which 
contains the miR-379/miR-410 cluster with 39 miRNAs). Interestingly, all the ncRNAs are 
regulated by a common cis-element and epigenetic control, resulting in a large polycistronic 
transcription unit (da Rocha et al., 2008; Seitz et al., 2004; Tierling et al., 2006). The Dlk1-
Gtl2 locus plays crucial roles in embryonic and adult stem cells (Ferrón et al., 2011; Lin et 
al., 2003; Snyder et al., 2013). However, whether the Dlk1-Gtl2 locus functions in HSCs and 
its underlying mechanism are largely uncharacterized. Here, we show how the Dlk1-Gtl2 
locus preserves functionality of LT-HSCs by inhibiting the PI3K-mTOR pathway and 
restricting mitochondrial metabolism.
RESULTS
Unique lncRNA Fingerprints in 17 Hematopoietic Cell Types Revealed Enrichment of 
lncRNAs from the Dlk1-Gtl2 Locus in CD49blo LT-HSCs
To systematically identify lncRNAs that might play a role in LT-HSCs, we isolated four 
hematopoietic stem and progenitor cells (HSPCs) (CD49blo LT-HSCs, CD49bhi IT-HSCs, 
ST-HSCs, and MPPs), four committed progenitors (common lymphoid progenitor [CLP], 
common myeloid progenitor [CMP], granulocyte-macrophage progenitor [GMP], and 
megakaryocyte-erythroid progenitor [MEP]), and nine mature lineage cells (B cell, T cell, 
NK cell, dendritic cell, monocyte, macrophage, granulocyte, megakaryocyte, and nucleated 
erythrocyte) by fluorescence-activated cell sorting (FACS) from the BM of C57BL/6J mice 
(Figure 1A; Figures S1A–S1F; Table S1). Next, we conducted 100 bp paired-end high-
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throughput RNA-seq on poly-A+ RNA and identified reliable lncRNAs using the stringent 
filtering strategies as previously reported (Alvarez-Dominguez et al., 2014) (Table S2; see 
Supplemental Experimental Procedures). Several known HSC markers (CD150, EPCR, and 
ESAM) were well captured, and the markers used for FACS exhibited consistency between 
transcript and protein levels, supporting the high quality of our RNA-seq data (Figure S1G). 
Our strategies yielded 4,204 lncRNAs, 1,606 of which (38.2%) were distinct from those in 
Ensembl databases. We also found that 860 (20.5%) of these lncRNAs overlapped with 
HSC-related lncRNAs recently reported in an elegant study (Luo et al., 2015) (Figure S1H). 
We then removed the least expressed transcripts by setting the threshold of FPKM 
(fragments per kilobase of transcript per million mapped reads) at >1 in at least one sample, 
which yielded 1,693 expressed lncRNAs. Compared to protein-coding genes, these lncRNAs 
had lower expression levels (Figure S1I) but higher tissue specificity (Figure S1J, p = 2.2 × 
10−16, Kolmogorov-Smirnov test), implying that they might play specific roles in different 
types of hematopoietic cells.
To investigate the ontogeny relatedness of hematopoietic cell types, we performed 
unsupervised hierarchical cluster analysis. The family tree analysis clearly showed that 
samples from HSPCs, progenitors, and lineages correlated positively, supporting the high 
specificity of lncRNAs (Figure 1B). We further performed principal components analysis 
(PCA) to measure and visualize differences among cell types. The PCA map showed 
CD49blo HSCs at the apex of the hematopoietic hierarchy (Figure 1C). We also observed the 
striking segregation of HSPCs, progenitor cells, and mature lineages, the latter of which 
further divided into three discrete clusters (lymphoid, myeloid, and erythroid) (Figure 1C). 
Together, both cluster and PCA analyses indicated that the lncRNA profiles distinguish 
CD49blo HSCs from other HSC subpopulations that eventually lost their functional capacity, 
supporting the previous report that permanently reconstituting CD49blo HSCs have the 
highest self-renewal ability (Benveniste et al., 2010).
We next determined the fingerprint lncRNAs in particular cell types. Based on specificity 
scores, we identified 461 (27.2% in 1693) fingerprint lncRNAs in 17 cell types that could be 
used as specific markers and might play essential roles during lineage commitment and 
differentiation (Figure 1D; Table S3). Only 954 of 13,775 (6.9%) protein-coding genes were 
identified as fingerprint genes, suggesting that lncRNAs have much higher percentages of 
lineage/stage-restricted gene expression. We specifically identified 12 lncRNAs enriched in 
CD49blo HSCs, three of which with the highest expression levels—Gtl2, Rian, and 
Gm26906—were derived from the imprinted Dlk1-Gtl2 locus on mouse chromosome 12qF1 
(Figure 1E). Intriguingly, H19 was also enriched in CD49blo HSCs. Furthermore, our RNA-
seq data revealed that all the ncRNAs expressed from the maternally inherited allele, starting 
from Gtl2 to Mirg, were exclusively enriched in CD49blo HSCs (Figure 1F), suggesting a 
potential role of ncRNAs from the Dlk1-Gtl2 locus in preserving CD49blo LT-HSCs.
Loss of Imprinting at the Dlk1-Gtl2 Locus Led to Deficiency in Fetal Liver HSCs
Both the intergenic germline-derived differentially methylated region (IG-DMR) and the 
Gtl2-DMR determine reciprocal expression of ncRNAs on the maternally inherited allele 
and protein-coding genes on the paternally inherited allele (Lin et al., 2003; Zhou et al., 
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2010). To determine the role of the Dlk1-Gtl2 locus in HSCs, we used the genetic mutant 
mice with straight knockout of IG-DMR (Lin et al., 2003). We bred the heterozygous IG-
DMR mice with WT mice and then performed PCR to determine allele-specific mutants 
with deletion of IG-DMR from maternally or paternally inherited allele (mat ΔIG or pat 
ΔIG) and their control littermates (Figures 2A and S2A). Since mat ΔIG embryos were lethal 
after E16, we used E15 embryos, at which stage HSCs are mainly located in fetal livers. To 
test gene expression in the Dlk1-Gtl2 locus in fetal liver LSK cells and adult HSCs, we 
compared RNA-seq data from four adult HSPCs, adult LSK cells, and E15 fetal liver LSK 
cells. Interestingly, we found that E15 fetal liver LSK cells exhibited expression patterns of 
lncRNAs in the Dlk1-Gtl2 locus similar to those of CD49blo HSCs, but not similar to those 
of the other adult HSPCs (Figure 2B), suggesting that the CD49blo subset of HSCs are 
enriched with a feature of fetal HSCs. Thus we were able to study the behaviors of HSCs 
isolated from E15 fetal liver and transplanted into adult recipients to reveal potential roles of 
the Dlk1-Gtl2 locus in HSCs.
We next investigated the roles of the Dlk1-Gtl2 locus in fetal liver HSCs. Consistent with a 
previous study (Lin et al., 2007), we observed several symptoms of anemia, including pale 
skin and few vessels, in the E15 mat ΔIG embryos (Figure S2B). Although total cell 
numbers in WT and ΔIG mutant fetal livers remained similar (Figure 2C), we indeed 
observed a 2-fold decrease in both frequency and absolute number of LSK cells in mat ΔIG, 
but not in pat ΔIG, fetal liver (Figures 2D and 2E). To assess the effect on HSCs, we used 
CD93 (Morrison et al., 1995) and CD38 (Randall et al., 1996) as fetal liver HSC surface 
markers. Flow cytometry analysis showed that both the frequency and absolute numbers of 
CD93+ HSCs, CD38hi HSCs, and CD38lo HSCs declined 2-fold in mat ΔIG fetal livers 
(Figures 2F–2I). However, except for an increase in the frequency of MEP and erythroid, we 
did not observe any change in the other progenitors and lineage cells, reflecting a relatively 
specific reduction in HSCs caused by loss of mat ΔIG (Figures S2C–S2F). We next 
quantified the gene expression levels of the Dlk1-Gtl2 locus by quantitative real-time PCR in 
both WT and mat ΔIG fetal liver cells. Interestingly, we observed almost no expression in 
lineage cells and no change between WT and mat ΔIG progenitors (Figure 2J), supporting 
previous observations that most progenitors and lineages cells showed no difference in 
frequency and absolute numbers. In contrast, we observed a substantial decrease in ncRNAs 
expressed from the maternally inherited allele (Gtl2, Rian, and Mirg) and an increase in 
Dlk1 (but not Rtl1 or Dio3) from the paternally inherited allele in fetal liver HSCs (Figure 
2J). To assess whether Dlk1 mediates HSC deficiency in the mat ΔIG mouse, we crossed 
mat ΔIG females with Tie2-cre+; Dlk1fl/fl males and found that deletion of Dlk1 could not 
fully rescue the decreased number of mat ΔIG fetal liver HSPCs, excluding the possibility 
that defective phenotype in mat ΔIG was due to increased Dlk1 expression (Figure S2G).
To assess whether loss of Gtl2 itself could lead to HSC deficiency, we used another genetic 
murine mutant of ΔGtl2, with a deletion of the first five exons of Gtl2 and Gtl2-DMR 
(Takahashi et al., 2009). Deletion of Gtl2 from the maternally inherited allele (mat ΔGtl2) 
caused perinatal death and repressed all the ncRNAs expressed from the maternally inherited 
allele, similar to the mat ΔIG mice (Zhou et al., 2010). Consistently, we found that HSPCs, 
but not progenitors and lineages, in the mat ΔGtl2 fetal livers exhibited decreased frequency 
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and absolute numbers (Figures 2K, 2L, S2H, and S2I). Together, these data indicate that loss 
of either mat ΔIG or Gtl2 per se leads to a deficiency in fetal liver HSCs.
Loss of Imprinting at the Dlk1-Gtl2 Locus Impaired Fetal Liver HSC Long-Term 
Reconstitution Capacity
To characterize the functional roles of Dlk1-Gtl2 locus in HSCs, we conducted a competitive 
repopulation assay by transplanting 5 × 104 or 5 × 105 whole fetal liver cells from mutants 
or their control littermates as donor cells (CD45.2), together with 1 × 105 recipient BM cells 
(CD45.1 hereafter) derived from the Ptprc mutant strain, into lethally irradiated recipient 
mice. In the 5 × 104 group, we found that overall engraftment from mat ΔIG was reduced 
1.4-fold, 1.8-fold, and 7.1-fold in primary (1st), secondary (2nd), and tertiary (3rd) recipients, 
respectively, compared to the control group (Figure 3A). Engraftment from pat ΔIG showed 
no difference (Figure S3A). Interestingly, we observed a significant myeloid lineage bias in 
the 2nd and 3rd mat ΔIG-transplant recipients (Figure 3A), consistent with a previous report 
of myeloid lineage bias associated with HSC aging and diminished total reconstitution 
potential (Beerman et al., 2010). In the 5 × 105 group, we observed a 2-fold decrease in the 
repopulation rate and a significant myeloid lineage bias from mat ΔIG only in the 3rd 
recipients, but no difference in the 1st or 2nd recipients (Figures S3B–S3D). We next 
analyzed donor HSCs in the recipient mice. In the 1st, 2nd, and 3rd recipients, the total cell 
numbers in BM were not affected; however, the absolute numbers of HSPCs, including 
CD49blo HSCs, declined significantly in mat ΔIG, but not in pat ΔIG, compared to control 
(Figures 3B and S3E–S3K). Intriguingly, we observed a significant decrease in the ratio of 
CD49blo/CD49bhi HSCs, from 30%/70% in control to 16%/84% in mat ΔIG, suggesting that 
deletion of IG-DMR from maternally inherited allele resulted in a reduction in LT-HSCs 
(Figure 3C). Further cell-cycle analyses in both fetal liver HSCs and donor CD49blo HSCs 
showed a decrease in the G0 phase fraction and a concomitant increase in the G1 phase 
fraction in mat ΔIG (Figures S3L and 3D). In addition, Kaplan-Meier survival analysis 
revealed that mice transplanted with mat ΔIG showed significantly reduced survival 
compared to controls (Figure 3E). To investigate whether impaired reconstitution capacity 
was due to functional defect in HSCs, we transplanted 150 sorted HSCs from WT and mat 
ΔIG fetal livers together with 2 × 105 rescue BM cells into recipient mice. We observed a 
striking reduction in reconstitution ability at 12 weeks posttransplantation in mat ΔIG 
compared to control (Figure 3F). Together, these results show that fetal liver cells from mat 
ΔIG mice have significantly reduced HSC numbers, accounting for reduced long-term 
reconstitution capacity.
To quantify functional HSCs, we further used ΔGtl2 mice to perform limiting dilution (5 × 
103, 1.5 × 104, and 5 × 104) competitive repopulating unit (CRU) assays. We observed a 2.1-
fold decrease in functional HSCs in mat ΔGtl2 mice compared to control (Figures 3G and 
3H). In the 5 × 104 group, 20 weeks posttransplantation, we observed a 2.2-fold decrease in 
the overall engraftment and a significant myeloid lineage bias from mat ΔGtl2 (Figure 3I). 
These data reveal that loss of either mat ΔIG or Gtl2 per se compromises fetal liver HSC 
long-term reconstitution capacity.
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Loss of Imprinting at the Dlk1-Gtl2 Locus Induced Hyperactivation of the PI3K-mTOR 
Pathway
We next sought to elucidate the molecular mechanisms underlying HSC defects from loss of 
imprinting at the Dlk1-Gtl2 locus. To this end, we performed RNA-seq in fetal liver LSK 
cells and identified 991 upregulated genes and 941 downregulated genes in mat ΔIG 
(Figures 4A and 4B). Gene Ontology (GO) enrichment analysis revealed that most of the 
upregulated GO terms enriched in the mat ΔIG LSK were related to proliferation, growth, 
development, and metabolism (Figure 4C; Table S4), suggesting that hyperactive 
proliferation and metabolism might be responsible for HSC deficiency in mat ΔIG mutants. 
Two terms (“regulation of cellular response to insulin stimulus” and “positive regulation of 
PI3K cascade”) were upregulated in mat ΔIG, leading us to hypothesize that the PI3K-
mTOR pathway might be hyperactivated in mat ΔIG HSCs. The PI3K-mTOR pathway is 
known to contribute to hematopoiesis, with downregulation of mTORC1 being essential for 
HSC self-renewal and maintenance, whereas abnormal activation of mTOR signaling is 
usually associated with leukemogenesis (Chen et al., 2008; Hirao and Hoshii, 2013; Lee et 
al., 2010). Furthermore, our previous study showed that activation of PI3K-AKT by PTEN 
mutation led to HSC exhaustion (Zhang et al., 2006). To test our hypothesis, we conducted 
three individual sets of experiments. First, to detect phospho (p)-AktS473 and p-mTORS2448 
activities in fetal liver HSCs, we performed immunostaining on sorted fetal liver LSK cells. 
Quantification of staining intensity revealed that, compared to control, mat ΔIG exhibited 
1.2-fold, 2-fold, and 1.9-fold increased activity of p-AktS473, p-mTORS2448, and p-
S6S235/236, respectively (Figures 4D–4G; Figures S4A and S4B). Second, to determine 
PI3K-mTOR activities, we performed intracellular flow cytometry and observed that median 
fluorescence intensities (MFIs) of p-AktS473, p-AktS308, and p-mTORS2448 were higher in 
LSK and HSCs, but not in progenitor and lineage cells, in mat ΔIG compared to WT 
(Figures 4H, 4I, and S4C). We also observed a significant increase in MFI of p-mTORS2481, 
indicating that both mTORC1 and mTORC2 were hyperactivated in mat ΔIG (Figure S4D). 
However, we observed no significant difference in MFIs of LKB1, p-AMPKαT172, p-
FoxO1T24/FoxO3aT32, or p-SGK1S78 (Figures S4E–S4H). Third, to test PI3K-mTOR 
activities in adult HSCs, we performed flow cytometry in recipient BM cells. Interestingly, 
MFIs of p-AktS473 and p-mTORS2448 in donor CD49blo HSCs were 145% and 133% higher, 
respectively, in mat ΔIG than in WT (Figures 4J and 4K). Taken together, these data suggest 
that loss of imprinting at the Dlk1-Gtl2 locus induces hyperactivation of the PI3K-mTOR 
pathway in both fetal liver HSCs and adult donor HSCs.
miRNAs in the Gtl2 Locus Suppressed Multiple Components of the PI3K-mTOR Pathway
Based on our RNA-seq data that the small ncRNAs were exclusively enriched in CD49blo 
HSCs together with Gtl2 (Figure 1F), we reasoned that these small ncRNAs might 
contribute to the hyperactivation of PI3K-mTOR signaling in the mutant HSCs. To test this 
idea, we performed small RNA-seq in both fetal liver HSCs and adult HSCs (Figure 5A). 
Intriguingly, we observed that small ncRNAs in the Gtl2 locus showed a widespread 
decrease in mat ΔIG fetal liver HSCs and exhibited an obvious enrichment in CD49blo HSCs 
relative to other adult HSPCs (Figures 5B and 5C). Moreover, ncRNAs in fetal liver HSCs 
and adult CD49blo HSCs showed striking similarity, suggesting that these ncRNAs might be 
specifically processed in HSCs. Combining the ncRNAs downregulated in mat ΔIG and 
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upregulated in CD49blo, we identified 15 miRNAs and 10 snoRNAs that might be 
responsible for HSC deficiency and PI3K-mTOR pathway hyperactivation (Figure 5D; Table 
S5).
Compared to snoRNAs, which function to methylate rRNA and snRNA (Cavaillé et al., 
1996), miRNAs are widely reported to repress translation or trigger mRNA degradation by 
recognizing complementary target sites in the 3′ UTRs of cognate mRNAs (Bartel, 2009). 
We used TargetScan 6.2 to predict which components in the PI3K-mTOR pathway might be 
targeted by these miRNAs (Figure 5E). Unexpectedly, 21 genes distributed over the entire 
PI3K-mTOR pathway contain one or multiple conserved binding sites of Gtl2-derived 
miRNAs in their respective 3′ UTRs (Figure 5F). We then used luciferase reporter assays to 
determine whether the corresponding mRNAs involved in the mTOR pathway were direct 
targets of these miRNAs. We first cloned full-length fragments of their 3′ UTRs into the 
luciferase reporter plasmid psi-CHECK2. Then we transfected either a mature miRNA 
duplex or a negative control with cognate 3′ UTR constructs into HEK293T cells and found 
that most of these miRNAs significantly repressed the relative luciferase activities of the 3′ 
UTRs of IGF1, IGF1R, IRS1, PIK3R1, AKT1, RHEB, RPTOR, PGC-1α, RPS6KB1, and 
EIF4E (Figure 5G). Moreover, mutation of cognate miRNA binding sites in the 3′ UTRs of 
RHEB and AKT1 abrogated their repression (Figures S5A and S5B). Further, we infected 
mouse MEF cells with lentiviruses that overexpress individual miRNAs. Our western blot 
data showed that miRNAs in the Gtl2 locus could repress expression of AKT1 and RPTOR 
at protein levels (Figures 5H and 5I). We also measured expression levels of AKT1 and 
RPTOR in HSCs and found that these were markedly higher in both fetal liver HSCs and 
donor CD49blo HSCs of mat ΔIG compared to WT (Figures S5C–S5F). Together, these data 
indicate that multiple components of the PI3K-mTOR pathway are de novo and direct 
targets of miRNAs derived from the Gtl2 locus.
To assess whether the HSC deficiency in mat ΔIG was due to downregulation of these 
miRNAs, we individually cloned 10 highly expressed miRNAs within this locus into 
lentiviral vectors and infected sorted fetal liver LSK cells with a pool of lentiviruses (Figure 
5J). 16 weeks posttransplantation, we found that the repopulation rate and absolute number 
of donor CD49blo HSCs in mat ΔIG HSCs were increased 2.9-fold and 5.7-fold, 
respectively, compared to WT HSCs after overexpression of these miRNAs. This implies 
that miRNAs in the Gtl2 locus are likely responsible for the HSC deficiency in mat ΔIG 
(Figures 5K and 5L).
Loss of Imprinting at the Dlk1-Gtl2 Locus Enhanced Mitochondrial Biogenesis, Metabolic 
Activity, and ROS Levels in HSCs
The PI3K-mTOR pathway serves as a sensor to integrate various environmental cues, such 
as nutrition and growth factors (Laplante and Sabatini, 2012). mTOR not only stimulates de 
novo synthesis of primary biosynthetic products such as proteins, nucleotides, and lipids, but 
also produces ATP by either enhancing mitochondrial activity through 4E-BP-dependent 
translational regulation (Morita et al., 2013) or activating PGC-1α, a master transcription 
regulator in the mitochondrial biogenic regulatory cascade (Cunningham et al., 2007). Since 
PGC-1α and EIF4E were directly targeted by miRNAs in the Gtl2 locus, we examined their 
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expression in mat ΔIG HSCs. Indeed, we found MFIs of PGC-1α and p-4E-BP1T37/46 in 
both fetal liver and donor CD49blo HSCs to be significantly increased in mat ΔIG (Figures 
6A–6D).
We then measured mitochondrial properties in fetal liver HSCs. Using flow cytometry with 
MitoTracker Green and DilC5, we observed a significant increase in mitochondrial mass and 
mitochondrial membrane potential (Δψ) in HSPCs of mat ΔIG (Figures 6E and 6F). Also, 
the mtDNA copy number increased markedly in mat ΔIG LSK cells, but not in Lin+ cells, 
compared to control (Figure 6G). Moreover, using transmission electron microscopy (TEM) 
technology to measure the morphology of mitochondrion, we observed increased 
mitochondrial number and folds of cristae in mat ΔIG HSCs (Figures 6H and 6I). 
Mitochondria constitute the most prominent source of ATP production mainly through the 
Krebs cycle and oxidative phosphorylation (OXPHOS) (Fernie et al., 2004). Thus, we next 
investigated glucose metabolism in mat ΔIG mutants. By performing flow cytometry with 2-
NBDG, a fluorescent glucose analog, we found increased glucose uptake in HSPCs of mat 
ΔIG (Figure 6J). Finally, we found greatly increased basal ATP levels in fetal liver LSK 
cells, but not in Lin+ cells, in mat ΔIG compared to contol (Figure 6K). In contrast, there 
was no difference in either mitochondrial activity or metabolism between pat ΔIG mutants 
and control (Figures S6A–S6D).
A hyperactive mTOR activity correlates with a high level of ROS (Jang and Sharkis, 2007). 
We next measured ROS levels using 2′,7′-dichlorodihydro-fluorescein diacetate (H2-
DCFDA) and observed markedly increased ROS levels in HSPCs of mat ΔIG (Figure 6L), 
consitent with a previous study using a similar mouse model, TSC1−/− (Chen et al., 2008). 
We next measured apoptosis in fetal liver HSCs and found a significantly higher percentage 
of apoptotic cells in HSPCs of mat ΔIG than of WT, which to a certain extent explains the 
reduced HSPC number in mat ΔIG (Figure 6M).
To further investigate the role of the Dlk1-Gtl2 locus in mitochondrial metabolism and ROS 
levels, we performed metabolic assays in mat ΔGtl2 mutants. We found that compared to 
control, HSPCs in the mat ΔGtl2 fetal livers exhibited increased mitochondrial mass, Δψ, 
glucose uptake, oxygen consumption rate, ROS levels, and apoptosis (Figures S6E–S6J). 
These findings support the likelihood that loss of imprinting at the Dlk1-Gtl2 locus leads to 
enhanced mitochondrial biogenesis, metabolic activity, and increased ROS levels in HSCs.
Pharmacological Inhibition of the PI3K-mTOR Pathway or ROS Production Partially 
Rescued HSC Deficiency in mat ΔIG Mutants
Given that loss of imprinting at the Dlk1-Gtl2 locus activates the PI3K-mTOR pathway and 
enhances mitochondrial biogenesis, metabolic activity, and ROS production, we asked 
whether pharmacological inhibition of either the PI3K-mTOR pathway or ROS production 
could abrogate the HSC defect caused by the Dlk1-Gtl2 locus deletion. We first transplanted 
sorted HSCs from WT and mat ΔIG fetal livers into lethally irradiated recipient mice. After 
stabilization of donor BM cells, we administered vehicle control or rapamycin, which 
interacts with peptidylproline isomerase FKBP12 and specifically inhibits mTORC1 activity, 
to the recipients daily (Figure 7A). Indeed, we found that the repopulation rate after 
rapamycin treatment in mat ΔIG HSCs was 715% higher compared to only 45.9% higher in 
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WT HSCs (Figure 7B). Likewise after rapamycin treatment, the absolute number of donor 
CD49blo HSCs in mat ΔIG was 311.5% higher compared to only 60.4% higher in WT mice 
(Figure 7C). Intracellular immunostaining revealed that rapamycin significantly reduced 
MFIs of p-mTORS2448, p-4E-BP1T37/46, and PGC-1α in donor CD49blo HSCs, supporting a 
decrease in mTORC1 activity following rapamycin administration (Figures 7D, S7A, and 
S7B). Furthermore, rapamycin clearly restored the mitochondrial mass, glucose uptake rate, 
percentage of G0 phase, and ROS levels in donor CD49blo HSCs (Figures 7E–7H). To 
further confirm that a hyperactivated PI3K-mTOR pathway led to HSC deficiency, we 
treated recipient mice with several different PI3K-mTOR pathway inhibitors, NVP-BEZ235 
(dual PI3K and mTOR inhibitor), PP242 (mTOR inhibitor), or MK-2206 (pan AKT 
inhibitor). Our transplantation data revealed that the decreased repopulation rates in mat ΔIG 
were abrogated at varying levels by administration of these inhibitors (Figures S7C and 
S7D). We next tested whether inhibition of ROS production could abrogate the HSC defects. 
We transplanted whole fetal liver cells into lethally irradiated recipient mice and fed them 
with water containing N-acetyl cysteine (NAC), an antioxidant to scavenge free radicals 
(Figure 7I). Intriguingly, we found that NAC treatment not only reduced ROS levels, but also 
partially restored the repopulation rate and absolute numbers of donor CD49blo HSCs in mat 
ΔIG (Figures 7J–7L). Overall, these data show that inhibiting either the PI3K-mTOR 
pathway or ROS production partially restores the HSC deficiency in mat ΔIG mutants.
DISCUSSION
In this study, by using global transcription profiling, we identified unique fingerprint 
lncRNAs in 17 hematopoietic cell types, in which lncRNAs in the Dlk1-Gtl2 locus were 
predominantly enriched in CD49blo LT-HSCs. Deletion of either IG-DMR or Gtl2 from the 
maternally inherited allele led to downregulation of Gtl2 and the downstream miRNA mega-
cluster, activation of the PI3K-mTOR pathway, enhanced mitochondrial biogenesis, 
enhanced metabolic activity, and increased ROS levels, eventually leading to HSC apoptosis 
(Figure 7M).
Specific Expression of lncRNAs in Hematopietic Stem, Progenitor, and Lineage Cells
Recent studies have revealed critical roles of epigenetic regulation in HSCs, including 
ncRNAs, DNA methylation, and histone modification (Cullen et al., 2014; Luo et al., 2015). 
Our study, using 17 hematopoietic stem, progenitor, and lineage cells, systematically 
identified unique fingerprints of lncRNAs, opening the opportunity to investigate the roles 
and underlying molecular mechanisms of lncRNAs in each cell type. From this framework, 
using unsupervised hierarchical cluster analysis and PCA on lncRNAs, we revealed that 
CD49blo HSCs stand at the apex of the hematopoietic hierarchy, and lncRNAs from the 
Dlk1-Gtl2 locus were predominantly enriched in the CD49blo HSCs.
ncRNAs from the Gtl2 Imprinting Locus Link Fetal Liver HSCs to Adult LT-HSCs and 
Function to Maintain LT-HSCs
A known feature of fetal HSCs distinctive from adult HSCs is their cycling status. The 
reason why functionality of adult stem cells, but not fetal HSCs, is associated with quiescent 
status has been elusive. It is therefore striking to find a link between fetal liver HSCs and the 
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adult CD49blo LT-HSCs in that they exhibit similar ncRNA expression patterns, particularly 
the ncRNAs from the maternally inherited allele in the Dlk1-Gtl2 locus (Figure 2B), 
suggesting that these Gtl2-derived ncRNAs play a role in maintaining both fetal and adult 
HSCs. Indeed, our study provides direct evidence that the Dlk1-Gtl2 locus is required for 
preservation of HSCs: loss of either mat ΔIG or Gtl2 per se in HSCs led to impaired HSC 
long-term reconstitution capacity. Consistent with previous studies that show that metabolic 
properties correlate with HSC functionality (Simsek et al., 2010; Suda et al., 2011; Takubo 
et al., 2013), our data further elucidate the role of the Dlk1-Gtl2 locus in preserving both 
fetal HSCs and adult LT-HSCs by inhibiting the PI3K-mTOR pathway and restricting 
mitochondrial metabolism.
An miRNA Mega-Cluster in the Gtl2 Locus Controls Mitochondrial Biogenesis and 
Metabolic Activity via Inhibiting the mTOR Pathway
The Dlk1-Gtl2 locus contains the largest cluster of miRNAs in the mammal genome and a 
large cluster of C/D box snoRNAs. A recent study revealed that Polycomb Repressive 
Complex 2 (PRC2) transcriptionally regulates the Gtl2 locus through DNA methylation at 
IG-DMR (Das et al., 2015). In this study, our RNA-seq data showed that these small 
ncRNAs were simultaneously expressed with Gtl2, supporting the hypothesis that these 
ncRNAs are transcribed as a large polycistronic transcription unit (Seitz et al., 2004; Tierling 
et al., 2006). Recent studies have linked the Dlk1-Gtl2 locus to energy metabolism. In one 
study, the Dlk1-Gtl2 locus was reported to be crucial for the transition to postnatal life by 
converging on the development of brown fat (Charalambous et al., 2012). In another study 
using a mouse model with the entire miR-379/miR-410 cluster deleted, researchers found 
that this cluster could control neonatal metabolic adaptation (Labialle et al., 2014). 
Consistently, our data reveal that deletion of either IG-DMR or Gtl2 in HSCs leads to 
downregulation of Gtl2 and the downstream miRNA mega-cluster and enhanced 
mitochondrial biogenesis and metabolic activity.
An interesting recent study showed that the mTOR pathway controls the transition from G0 
to GAlert phase in quiescent stem cells, which functions as an “alerting” mechanism to 
enhance tissue regenerative function (Rodgers et al., 2014). Our study further reveals that the 
miRNA mega-cluster in the Gtl2 locus suppresses the entire PI3K-mTOR pathway and 
inhibits mitochondrial biogenesis and metabolic activity, suggesting the essential roles of 
metabolic states in preserving LT-HSCs.
EXPERIMENTAL PROCEDURES
Mice
All mice used in this study were housed in the AAALAC-accredited animal facility at the 
Stowers Institute for Medical Research (SIMR) and handled according to SIMR and 
National Institutes of Health guidelines. All procedures involving experimental animals were 
approved by the Institutional Animal Care and Use Committee (IACUC) of SIMR. 
C57BL/6, Ptprc, and Dlk1 floxed mice were purchased from Jackson Laboratory.
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Total RNA was isolated using Trizol (Invitrogen). Sequencing libraries were prepared from 
10–100 ng total RNA using the TruSeq RNA Sample Preparation Kit v2 (Illumina).
Intracellular Flow Cytometry
Cells from E15.0 fetal livers or recipient BM were initially stained with surface markers for 
30–60 min at 4°C and washed with PBS (2% FBS). Cells were then fixed and permeabilized 
with Cytofix/Cytoperm buffer (BD Biosciences) for 30 min and stained on ice with 
individual primary antibody or isotype control for 30 min. Samples were then incubated with 
fluorescent dye conjugated secondary antibodies (Molecular Probes) for 30 min and 
analyzed by flow cytometry. FlowJo software was used to calculate the MFI for each 
sample.
Luciferase Reporter Assay
HEK293T cells (5 × 104/well) were seeded into 24-well plates 1 day before transfection. 
200 ng of each 3′ UTR construct was co-transfected with 20 nM miRNA mimics or 
scramble control using Lipofectamine 2000 (Invitrogen) following the manufacturer’s 
instructions. Cells were harvested 48 hr after transfection, and then Firefly and Renilla 
luciferase activities were measured using the dual-luciferase reporter kit (Promega) on 
Victor3 Multilabel Plate Counter (Perkin Elmer).
Statistics
Values are shown as the mean ± SD or SEM as indicated. All statistical analyses were 
generated using GraphPad Prism 5 (GraphPad Software). Student’s t test was used for 
comparisons between two groups, whereas one-way ANOVA followed by Tukey’s post hoc 
tests and two-way ANOVA analysis followed by Bonferroni’s post hoc tests were used for 
comparisons among multiple groups. Log rank (Mantel-Cox) test was used for Kaplan-
Meier survival. Statistical significance was defined as p < 0.05.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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• Transcriptome profiling reveals Gtl2-derived ncRNA enrichment in LT-HSCs
• Loss of Dlk1-Gtl2 imprinting leads to functional defects in fetal liver HSCs
• miRNAs of the Dlk1-Gtl2 locus suppress components of the entire PI3K-
mTOR pathway
• PI3K-mTOR inhibition restricts mitochondrial metabolism to preserve LT-
HSC function
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Figure 1. Unique lncRNA Fingerprints in 17 Hematopoietic Cell Types Revealed Enrichment of 
lncRNAs from the Dlk1-Gtl2 Locus in CD49blo LT-HSCs
(A) Schematic representation of the hematopoietic hierarchy showing cell types used in this 
study and workflow for lncRNA discovery.
(B) A dendrogram displays hierarchical cluster analysis from 1,693 expressed lncRNAs 
based on Pearson correlations of log2 (FPKM + 2−11) values. The samples from HSPCs, 
progenitors, and lineage cells are surrounded by red, yellow, and purple rectangles, 
respectively.
(C) Population-distance analysis of 1,693 expressed lncRNAs shown in two principal 
components (PCs 1–2). Cell types are color-coded, labeled by name, and surrounded by 
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different ellipses. HSPCs, red; committed progenitor cells, yellow; myeloid cells, violet; 
lymphoid cells, blue; nucleated erythrocytes, pink.
(D) Heat map of cell-type-specific lncRNA fingerprints based on cell specificity scores 
(color indicates specificity scores; darker corresponds to higher specificity scores). 
Representative fingerprint lncRNAs in different cell types are shown on the right.
(E) Schematic representation of the Dlk1-Gtl2 locus. Genes (rectangles) on the maternally 
inherited allele (in red) and the paternally inherited allele (in blue) are depicted. miRNA and 
C/D snoRNA genes are shown by hairpin loops and triangles, respectively. Arrows indicate 
the transcription directions, with the horizontal dash line indicating the hypothesis that Gtl2, 
anti-Rtl1, Rian, and Mirg may constitute a large polycistronic transcription unit. The IG-
DMR and Gtl2-DMR are unmethylated (open circles) on the maternally inherited allele but 
methylated (filled circles) on the paternally inherited allele.
(F) UCSC Genome Browser images show RNA-seq signal as the density of mapped reads in 
the whole Dlk1-Gtl2 locus.
See also Figure S1 and Table S1, Table S2, and Table S3.
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Figure 2. Loss of Imprinting at the Dlk1-Gtl2 Locus Led to Deficiency in Fetal Liver HSCs
(A) Schematic representation of mating strategy to generate allele-specific mutant embyros.
(B) RNA-seq analysis of lncRNAs in the Dlk1-Gtl2 locus in E15 fetal liver LSK, adult BM 
LSK, and four adult HSPC populations.
(C) Absolute numbers of total fetal liver cells (n = 6).
(D–I) Flow cytometric analyses to show the gate, frequency (of total nucleated cells 
[TNCs]), and absolute numbers of LSK cells, CD93+ HSCs, and CD38 HSCs in WT and 
ΔIG fetal liver (n = 6).
(J) Tri-color heat map shows quantitative real-time PCR analysis of Dlk1-Gtl2 locus genes 
in HSPCs, progenitors, and lineage cells from WT and mat ΔIG fetal livers. β-Actin was 
used as an internal control.
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(K and L) Frequency in TNCs and absolute numbers of HSPCs in WT and ΔGtl2 fetal liver 
(n = 3). Error bars, SEM; *p < 0.05; **p < 0.01. See also Figure S2 and Table S1, Table S2, 
and Table S6.
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Figure 3. Loss of Imprinting at the Dlk1-Gtl2 Locus Impaired Long-Term Reconstitution 
Capacity of Fetal Liver HSCs
(A) 5 × 104 WT or mat ΔIG fetal liver cells were transplanted with 1 × 105 rescue cells into 
irradiated recipients. At 16 weeks posttransplant, BM isolated from 1st recipients was 
transplanted into 2nd recipients and, at 16 weeks post 2nd transplant, from 2nd into 3rd 
recipients at a dosage of 1 ×106 cells per mouse. Peripheral blood (PB) was analyzed for 
percent donor repopulation at the indicated number of weeks after transplants (top panels) 
and for percent mature donor-derived B, T, and myeloid cells (bottom panels) (n = 10).
(B) Absolute numbers of HSPCs in the BM from 3rd recipients (n = 5).
(C) Percentage of CD49blo and CD49bhi HSCs in the BM from 3rd recipients (n = 5).
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(D) Cell-cycle analysis of CD49blo HSCs in BM from 1st recipients (n = 5).
(E) Kaplan-Meier survival curve for 1st, 2nd, and 3rd transplant recipients (n = 10).
(F) 150 sorted CD93+ HSCs from WT or mat ΔIG fetal livers were transplanted with 2 ×105 
rescue cells into irradiated recipients. PB analysis for percent engrafted donor cells at the 
indicated number of weeks posttransplantation is shown.
(G–I) CRU frequency was determined in (H) using ELDA (Extreme Limiting Dilution 
Analysis). PB of the 5 ×104 group was analyzed for percent donor repopulation at the 
indicated number of weeks posttransplantation and for percent mature donor-derived B, T, 
and myeloid cells (I) (n = 10).
Error bars, SD; *p < 0.05; **p < 0.01. See also Figure S3.
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Figure 4. Hyperactivation of the PI3K-mTOR Pathway in mat ΔIG Fetal Liver HSPCs
(A) Poly-A+ RNA-seq workflow.
(B) MA plot (plot of mean log2 difference versus mean log2 intensity) for differential 
expression analysis between WT and mat ΔIG fetal liver LSK cells.
(C) GO enrichment analysis using −log10 of the uncorrected p value as x axis. The 
upregulated or downregulated GO terms in mat ΔIG are shown in red or blue, respectively. 
The numbers indicate the amount of enriched genes in each term.
(D–G) Representative image and quantification of staining intensity of LSK cells sorted 
from WT and ΔIG fetal livers for p-AktS473 (n ≥ 43) and p-mTORS2448 (n ≥ 152).
(H–K) MFIs of p-AktS473 and p-mTORS2448 in fetal liver HSCs (H and I, n = 4) and donor 
CD49blo HSCs from BM of 3rd recipients (J and K, n ≥ 4).
Error bars, SEM (H and I) or SD. Scale bars, 5 μm. *p < 0.05; **p < 0.01; ***p < 0.001. See 
also Figure S4, Table S4, and Table S7.
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Figure 5. miRNAs in the Dlk1-Gtl2 Locus Repressed Multiple Components of the PI3K-mTOR 
Pathway
(A) Small RNA-seq workflow.
(B and C) UCSC Genome Browser images show small RNA-seq signal as the density of 
mapped reads in the whole Dlk1-Gtl2 locus from either fetal liver HSCs (B) or adult HSPCs 
(C).
(D) The Venn diagram shows the overlap between ncRNAs downregulated in mat ΔIG and 
upregulated in CD49blo HSCs. The miRNAs are listed on the bottom.
(E) Schematic representation of the PI3K-mTOR pathway.
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(F) Putative miRNAs and their binding sites in 21 genes of the PI3K-mTOR pathway.
(G) Luciferase reporter assays performed to determine functional miRNA binding sites (n = 
2).
(H and I) Western blotting assays performed to detect expression of AKT1 and RPTOR in 
mouse MEF cells infected with miRNA overexpressing lentivirus. β-ACTIN was used as 
internal control.
(J) Scheme for transplantation assay rescued by overexpression of 10 miRNAs in Gtl2 locus.
(K) Quantification of functional HSCs by transplantation assay (n = 6).
(L) Absolute numbers of CD49blo HSCs in recipient mice at 16 weeks posttransplantation (n 
= 6).
Error bars, SEM (G) or SD; *p < 0.05; ns, not significant. See also Figure S5 and Table S5, 
Table S6, and Table S7.
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Figure 6. Loss of Imprinting at the Dlk1-Gtl2 Locus Enhanced Mitochondrial Biogenesis and 
Metabolic Activity and Increased ROS Levels in HSCs
(A–D) MFI of PGC-1α and p-4E-BP1T37/46 in fetal liver HSCs (A and B, n = 3) and donor 
CD49blo HSCs from BM of 3rd recipients (C and D, n ≥ 4).
(E) Mitochondrial mass of WT and mat ΔIG cells assayed by MitoTracker Green staining (n 
= 3).
(F) Mitochondrial membrane potential of WT and mat ΔIG cells assayed by DilC5 staining 
(n = 3).
(G) Relative mitochondria DNA copy number of WT and mat ΔIG cells assayed by qRT-
PCR (n = 2).
(H and I) Representative TEM images of mitochondrial morphology in WT and mat ΔIG 
LSK cells.
(J) Glucose uptake of WT and mat ΔIG cells assayed by 2-NBDG (n = 3).
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(K) Relative basal ATP levels of WT and mat ΔIG cells (n = 2).
(L) ROS levels of WT and mat ΔIG cells assayed by H2-DCFDA (n = 3).
(M) Percentage of apoptotic cells in WT and mat ΔIG cells assayed by Annexin V and 7-
AAD staining (n = 3).
Error bars, SEM or SD (C and D). *p < 0.05; **p < 0.01; ***p < 0.001. See also Figure S6 
and Table S7.
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Figure 7. Rapamycin and NAC Partially Rescued Defective HSCs and Metabolic Effects Due to 
Loss of Imprinting at the Dlk1-Gtl2 Locus
(A) Scheme for rapamycin administration.
(B) Repopulation assay for rapamycin administration at 12 weeks posttransplantation (n ≥ 
4).
(C) Absolute numbers of CD49blo HSCs in recipient mice with rapamycin administration at 
12 weeks posttransplantation (n ≥ 4).
(D) MFI of p-mTORS2448 in donor CD49blo HSCs from BM of mice treated with rapamycin 
(n ≥ 4).
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(E–H) Mitochondrial mass, glucose uptake, cell-cycle analysis, and ROS levels in donor 
CD49blo HSCs from BM of mice treated with rapamycin (n ≥ 4).
(I) Scheme for NAC administration.
(J) Repopulation assay for NAC administration at 16 weeks posttransplantation (n = 6).
(K) Absolute numbers of CD49blo HSCs in recipient mice fed with NAC water at 16 weeks 
posttransplantation (n = 6).
(L) ROS levels in donor CD49blo HSCs from BM of mice fed with NAC water (n = 6).
(M) Model depicting an essential role of the Dlk1-Gtl2 locus in preserving HSCs by 
inhibiting the PI3K-mTOR pathway and restricting mitochondrial metabolism.
Error bars, SD; *p < 0.05; **p < 0.01; ***p < 0.001. See also Figure S7 and Table S7.
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